Javier Cortés tells his findings from ASCENT-03 as reported to ESMO 2025 in Berlin with antibody drug conjugate as initial therapy for TNBC...
resectable-gastric-and-ge-junction adenocarcinoma-radiation-therapy-no-help
Domenica Lorusso MD PhD: Initial therapy with Pembrolizumab added to chemoradiotherapy boosts survival in high-risk locally advanced cervix...
James Larkin FRCP, PhD talks about the big changes in survival prospects for patients with advanced and metastatic melanoma that have take...
The cancer prevention benefit of vaccination against the human papilloma virus cancer prevent are slowly accruing thanks to European...
Rebecca Dent surveys the most recent ESMO Annual Meeting to prepare our thoughts for the ESMO 2025 meeting
bart-neyns-md-phd-injectng-cells-into-cranial-cavity-for-recurrent-glioblastoma-long-survival
Timothy Yap MD PhD MBBS
selective PARP inhibitor promise in breast, ovarian, pancreatic, prostate tumors.
Stacey Kenfield and June Chan UCSF
